Australia News
-
Phylogica gets Aus patent for Phylomer library
Australia | News | By BioSpectrum Bureau | 0 Comment | 25 Mar, 2013
Singapore: Phylogica has received a core patent in Australia (Registration no: 2009251209; Divisional of AU 2008200790)...Read more
-
Top brass changes at medical device major iSonea
Australia | News | By BioSpectrum Bureau | 0 Comment | 07 Jan, 2014
Singapore: In a bid to shift its focus from technology development to sales, Australia's top medical device manufacturer...Read more
-
Logistics provider STL Warehousing expanding
Australia | News | By BioSpectrum Bureau | 0 Comment | 12 Jul, 2013
Singapore: In a move to venture into the global market, Australia's leading healthcare logistics provider STL Warehousin...Read more
-
GI Dynamics gets FDA nod for diabetes and obesity trial
Australia | Regulatory | By BioSpectrum Bureau | 0 Comment | 24 Aug, 2012
Singapore: GI Dynamics received conditional approval from the US FDA to commence a pivotal clinical trial of the EndoBar...Read more
-
What are the hurdles before stem cell research?
Australia | Analysis | By Piyusha Chatterjee | 4 Comment | 31 Jan, 2013
The pioneering research of Nobel Laureates Sir John Gurdon and Dr Shinya Yamanaka on reprogramming adult stem cells has ...Read more
-
Takeda R&D filed 7 NDAs in the last 8 months
Australia | News | By BioSpectrum Bureau | 0 Comment | 05 Oct, 2012
Singapore: Takeda Global Research and Development, a wholly owned subsidiary of Takeda Pharmaceutical, has filed seven n...Read more
-
Start-up to commercialize blood collection tube
Australia | News | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2012
Singapore: Australia's Medical Research Commercialization Fund (MRCF) and the Uniseed Commercialization Fund have jointl...Read more
-
US firm wins stem cell drug patent in Australia
Australia | News | By BioSpectrum Bureau | 0 Comment | 19 Feb, 2013
Singapore: US-based Osiris Therapeutics, which develops and markets stem cell products to treat serious medical conditio...Read more
-
iSonea launches first mobile asthma technology
Australia | News | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2012
Singapore: Medical technology company iSonea launched its first asthma management smartphone app, AsthmaSense, for iPhon...Read more
-
Bionomics launches ovarian cancer trial
Australia | News | By BioSpectrum Bureau | 0 Comment | 24 May, 2012
Singapore: Bionomics Limited launched a phase I/II clinical trial of its vascular disrupting agent BNC105 in women with ...Read more
-
Sigma marks a century of achievements
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 06 Jun, 2012
After witnessing a turbulent year of 2009-10, the focus of Australia-based Sigma Pharmaceuticals in 2011 was restructu...Read more
-
HealthLinx meets ovarian cancer test needs
Australia | News | By BioSpectrum Bureau | 0 Comment | 12 Apr, 2012
There is no reliable diagnostic blood test for ovarian cancer. The current market gold standard, CA125, is used as an ai...Read more
-
BS Survey: Healthcare is getting smarter in Asia
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 30 Nov, 2012
...Read more
-
BioDiem gets license for novel vaccine technology
Australia | News | By BioSpectrum Bureau | 0 Comment | 08 Jun, 2012
Singapore: Australian National University (ANU) has granted an exclusive license to vaccine development company, BioDiem...Read more
-
Challenge No 2: Missing industry hubs
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 17 May, 2012
The Asia Pacific region, barring the developed nations of Australia and Singapore, needs "critical mass" where interdepe...Read more
-
Aussies to get breast cancer treatment analysis
Australia | News | By BioSpectrum Bureau | 0 Comment | 07 Jan, 2014
Singapore: Australian women will potentially have greater access to the only genomic test validated to predict whether p...Read more
-
Cancer Therapeutics reveals new targeted drug
Australia | News | By BioSpectrum Bureau | 0 Comment | 05 Jul, 2012
Singapore: Cancer Therapeutics, an Australian company focused on translating cancer biology research into novel treatmen...Read more
-
Australia approves Hospira's biosimilar
Australia | News | By BioSpectrum Bureau | 0 Comment | 20 Aug, 2015
Singapore: Hospira's Inflectra (infliximab), the first monoclonal antibody (mAb) biosimilar therapy, has been registered...Read more
